Katrina Pedersen: Not many people realize that there is NO prospective interventional trial data for FOLFIRI or for a powered Taxane cohort in Small Bowel Adenocarcinoma
Katrina Pedersen, Gastrointestinal Oncologist at Siteman Cancer Center, shared a post by SWOG Cancer Research Network on X/Twitter, adding:
”Not many people realize that there is NO prospective interventional trial data for FOLFIRI or for a powered Taxane cohort in Small Bowel Adenocarcinoma. I know—hard to believe! Thanks SWOG Cancer Research Network and Michael Overman for dedicating resources to S1922 to fill this critical gap.”
Quoting SWOG Cancer Research Network’s post:
”Small Bowel Adenocarcinoma is often treated with therapies used for gastric or colorectal cancer. Study S1922 tests 2 treatments to learn whether they work specifically against small bowel adenocarcinoma. Learn more here or call 1-800-4-CANCER. Ask about S1922.”
Source: Katrina Pedersen/Twitter and SWOG Cancer Research Network/Twitter
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023